Cellebrite CRO sells shares for RSU tax obligations

Cellebrite DI Ltd. executive Jewell Marcus, Global Chief Revenue Officer, reported selling 411 ordinary shares of Cellebrite DI Ltd. on August 12, 2026 at a weighted average price of $16.0678 per share.

Rhea-AI Filing Summary

Cellebrite DI Ltd. executive Jewell Marcus, Global Chief Revenue Officer, reported selling 411 ordinary shares of Cellebrite DI Ltd. on August 12, 2026 at a weighted average price of $16.0678 per share. A footnote explains the shares were originally granted as RSUs on February 11, 2025 and that the disposition is associated with tax obligations arising from the RSU vesting, effectively a sale to cover taxes. After this transaction, Marcus directly holds 439,690 ordinary shares. The transaction was not marked as conducted under a Rule 10b5-1 trading plan.

Insider Trade Summary

Net Seller: 411 shares

Net Sell 1 txn

Insider Jewell Marcus

Role Global Chief Revenue Officer

Sold 411 shs ($7K)

Type	Security	Shares	Price	Value
Sale	Ordinary shares, par value NIS 0.00001 F1, F2	411	$16.0678	$7K

Holdings After Transaction: Ordinary shares, par value NIS 0.00001 — 439,690 shares (Direct)

Footnotes (2)

1. F1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.0086 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Key Figures

Shares sold: 411 shares Weighted average sale price: $16.0678 per share Post-transaction holdings: 439,690 shares +3 more

6 metrics

Shares sold 411 shares Ordinary shares sold on August 12, 2026

Weighted average sale price $16.0678 per share Average price for the 411 shares sold

Post-transaction holdings 439,690 shares Direct ownership after the reported sale

Sale price range $16.0086–$16.08 per share Range of prices for multiple sale transactions

RSU grant date February 11, 2025 Date the disposed shares were granted as RSUs

Transaction date August 12, 2026 Date of the reported share sale

Key Terms

restricted stock units ("RSUs"), weighted average price, tax obligations

3 terms

restricted stock units ("RSUs") financial

"The shares reported as disposed herein were granted ... in the form of restricted stock units ("RSUs")."

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

tax obligations financial

"The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cellebrite (CLBT) insider Jewell Marcus report in this Form 4?

Jewell Marcus reported a sale of 411 ordinary shares of Cellebrite on August 12, 2026 at a weighted average price of $16.0678 per share, with the transaction linked to tax obligations from RSU vesting.

How many Cellebrite (CLBT) shares does Jewell Marcus hold after this transaction?

Following the reported sale, Jewell Marcus directly holds 439,690 ordinary shares of Cellebrite DI Ltd. This figure reflects the position after the 411-share disposition associated with tax obligations from vested RSUs.

At what prices were the CLBT shares sold in Jewell Marcus’s Form 4 filing?

The reported weighted average sale price was $16.0678 per share. A footnote states the individual trades occurred in multiple transactions at prices ranging from $16.0086 to $16.08 per share.

Was the CLBT insider sale by Jewell Marcus part of a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes do not indicate a trading plan, so the sale is not reported as made under a Rule 10b5-1 plan.

Why were Jewell Marcus’s CLBT shares disposed of according to the Form 4?

A footnote explains the disposed shares were granted as RSUs on February 11, 2025, and the disposition is associated with tax obligations related to the vesting of those RSUs, indicating a tax-related sale.

What role does Jewell Marcus hold at Cellebrite (CLBT) in this Form 4?

Jewell Marcus is identified as the company’s Global Chief Revenue Officer. The reported transaction therefore reflects an equity-related tax sale by a senior executive officer of Cellebrite DI Ltd.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/13/2026 - 08:24 AM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jewell Marcus

(Last) (First) (Middle)

94 SHLOMO SHMELZER ROAD

(Street)

PETAH TIKVA 4970602

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cellebrite DI Ltd. [ CLBT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Global Chief Revenue Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary shares, par value NIS 0.00001	08/12/2026	08/12/2026	S		411(1)	D	$16.0678(2)	439,690	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares reported as disposed herein were granted on February 11, 2025, in the form of restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.0086 to $16.08, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

	/s/ Marcus Jewell	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)